Article info
Original Articles: Ovarian Cancer
Family History of Cancer Rather Than p53 Status Predicts Efficacy of Pegylated Liposomal Doxorubicin and Oxaliplatin in Relapsed Ovarian Cancer
- Address correspondence and reprint requests to Maria Ornella Nicoletto, Oncologia Medica 1, Istituto Oncologico Veneto IRCCS, via Gattamelata 64, 35128 Padova, Italy. E-mail: mariaorn{at}libero.it.
Citation
Family History of Cancer Rather Than p53 Status Predicts Efficacy of Pegylated Liposomal Doxorubicin and Oxaliplatin in Relapsed Ovarian Cancer
Publication history
- First published July 1, 2009.
Online issue publication
July 01, 2009
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2009 by IGCS and ESGO